title: The Mount Sinai experience with orthotopic liver transplantation for benign tumors: brief report and literature review: case reports.
abstract: Orthotopic liver transplantation (OLT) is performed for benign hepatic lesions that are symptomatic, too large to be resected, have a malignant transformation potential, cause debilitating/life-threatening manifestations, or in patients experiencing posthepatectomy acute liver failure. Among benign tumors, polycystic liver disease (PLD) is the most common indication for OLT alone, or combined liver-kidney transplantation. Our 10-year experience with OLT for benign tumors includes two patients with PLD and one with a benign giant fibrous tumor. In this report, we present our experience with OLT for benign liver tumors, commenting on relevant published studies.
authors.affiliation: Recanati-Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY, USA.
authors.forename: M E
authors.initials: ME
authors.lastname: Schwartz
authors.forename: S
authors.initials: S
authors.lastname: Roayaie
authors.forename: M M
authors.initials: MM
authors.lastname: Konstadoulakis
authors.forename: I P
authors.initials: IP
authors.lastname: Gomatos
authors.forename: C M
authors.initials: CM
authors.lastname: Miller
mesh_terms: D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery*; D016031:Liver Transplantation / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000175:diagnosis; D011183:Postoperative Complications; D016896:Treatment Outcome